Skip to Content

Research Staff

Dana C. Baiu, PhD

Dana C. Baiu, PhD

Assistant Scientist

Saswati C. Bhattacharya, PhD

Saswati C. Bhattacharya, PhD

Assistant Scientist

No Photo Available

Peter Carlson

Medical Student

Sarah M. Laudon

Sarah M. Laudon

Student Researcher

Meghan R. McElreath

Meghan R. McElreath

Student Researcher

Sorabh Singhal

Sorabh Singhal

Student Researcher

Matthew J. Wolf

Matthew J. Wolf

Student Researcher

 

Dana C. Baiu, PhD

Dana holds an M.S. in Cell and Molecular Biology and a Ph.D. in Cell Biology from the University of Bucharest, Romania. Her graduate and postgraduate research focused on the role of antigen presentation in the modulation of immune responses in the context of vaccination, autoimmunity and transplantation. Currently, her research focuses on the study of gamma-delta T cells during hematopoietic cell recovery after bone marrow transplantation to improve therapies for pediatric solid malignancies, and on magnetic nanoparticle targeting to GD2-expressing tumors to improve diagnosis and imaging of pediatric neuroblastoma.

Tom D. DuBois

Tom is a senior undergraduate student at the University of Wisconsin-Madison majoring in Neurobiology with a Certificate in Global Health. He is graduating in May of 2013 and hopes to attend medical school in the fall. He plans to pursue a career in pediatrics. Tom enjoys volunteering at two local, free, medical clinics and also serves as the Director of Development for a non-profit organization in Madison called the Healthy Classrooms Foundation. Tom’s research in the Otto Lab focuses on the anti-tumor properties of the novel phospholipid ether molecule CLR1404.

Sarah M. Laudon

Sarah is an undergraduate student at the University of Wisconsin-Madison majoring in Genetics with a Certificate in Global Health. She will be graduating in 2015 and plans to attend medical school to work in a pediatrics field. Her research is focusing on the phospholipid ether molecule CLR1404 and its potential to be of use for neuroblastoma treatment.

Roberta C. Marino, PhD

A native of Brazil, Roberta obtained her B.S. in 2001 in Biological Sciences at Mackenzie Presbyterian University, São Paulo. She graduated with a Master of Science degree in 2004 from the Federal University of São Paulo with work focusing on hematopoietic stem cell differentiation and mesenchymal stem cell (MSC) therapy geared towards cure for neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (Lou-Gehrig-Disease). Roberta obtained her Ph.D. in Biomedical Sciences in a joint program administered by the Federal University of São Paulo, Brazil, the University of Tennessee and St. Jude Children’s Research Hospital in Memphis, Tennessee. Roberta’s thesis was on multipotent mesenchymal stromal cells and their differentiation into osteoprogenitors. She later joined the Department of Neonatology at CHOP to work on the influence of certain growth factors on stress hematopoiesis. Her current research is focusing on the evaluation of a novel compound for simultaneous tumor imaging and cancer therapy.

Meghan R. McElreath

Meghan is an undergraduate student at the University of Wisconsin-Madison majoring in Medical Microbiology and Immunology with a Certificate in Global Health. Her research within the Otto Lab is focused on the use of iron nanoparticles to specifically target and treat GD2-expressing tumors such as neuroblastoma.

Sorabh Singhal

Sorabh is an undergraduate student at the University of Wisconsin-Madison, class of 2016. Currently majoring in Biochemistry, he plans to pursue a career in medicine. The newest addition to the Otto Laboratory, he is currently being introduced into the lab environment and trained in various lab techniques.

Research Group Alumni

Bryan D. Menapace

Bryan D. Menapace

Bryan was an undergraduate student at the University of Wisconsin-Madison majoring in Biochemistry with a Certificate in Business. He worked the Otto Lab from October 2001 - December 2012, focusing on induction of apoptosis and necrosis in neuroblastoma through targeted inhibition of the Akt-pathway, and specific neuroblastoma tumor targeting and killing using nanoparticles. Bryan has been accepted to Medical School to start in summer 2013. His goal is to become a pediatrician.


Last updated: 03/12/2014
webmaster [at] pediatrics [dot] wisc [dot] edu
Copyright © 2014 The Board of Regents of the University of Wisconsin System